Whether this might be due to the small number of patients, to enrichment in luminal subtypes, to the combination with hormonotherapy or to the absence of chemotherapy remains unclear indications for tamoxifen 89 and mortality IRR 1

Whether this might be due to the small number of patients, to enrichment in luminal subtypes, to the combination with hormonotherapy or to the absence of chemotherapy remains unclear indications for tamoxifen 89 and mortality IRR 1